New Finnish company to develop a nasal spray vaccine for COVID-19
The spin-out from the Universities of Helsinki and Eastern Finland will leverage years of research to test and bring to market a nasal spray vaccine against COVID-19.
List view / Grid view
The spin-out from the Universities of Helsinki and Eastern Finland will leverage years of research to test and bring to market a nasal spray vaccine against COVID-19.
Researchers have shown how ciprofloxacin, a fluoroquinolone, affects mitochondrial DNA, and could be the cause of side effects experienced from use of the drug...
The results of the study were said to be concerning because previous research had linked psychotropic drug use among older people and patients with dementia to several adverse events...
Current advice points to single or occasional use of the drug, and it is not recommended to be used for longer than four weeks...
Initiating an opioid analgesic reduced the use of antipsychotics and benzodiazepines in persons with Alzheimer's disease...
Researchers have found that the long-term proton pump inhibitor use does not increase the risk of hip fracture among persons with Alzheimer's disease...